Brought to you by:
Penumbra announces FDA clearance of Lightning Flash 2 for the treatment of PE
Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Flash 2, the next generation computer assisted vacuum thrombectomy (CAVT) system to remove venous thrombus and treat pulmonary embolism (PE), a press release states. Lightning Flash…
CX united: Vascular world set to converge with challenging cases
The World Federation of Vascular Societies (WFVS) is bringing the vascular world together at CX 2024 to chew over both challenging cases and leadership challenges. The pair of sessions is part of the legacy left by Professor Roger M. Greenhalgh,…
Paclitaxel controversy: Yes, device restrictions did cause harm
“Unfortunately, we are doing worse for our patients today,” were the sobering thoughts of Eric Secemsky (Boston, United States) during a late-breaking presentation in this morning’s Peripheral Arterial Controversies programme. Among several presentations on paclitaxel safety, he reported that: yes,…
SVS launches Vascular Board Certification Model Task Force
The Society for Vascular Surgery (SVS) Executive Board has established the Vascular Board Certification Model Task Force to deliver a final report entitled “Free-standing or federated Board certification: An analysis of the optimal path forward for vascular surgery” by the…
SVS announces candidates for 2024–25 vice president
The Society for Vascular Surgery (SVS) has announced Linda Harris, MD, and Palma Shaw, MD, as the candidates for the upcoming election for SVS vice president. “This is an exciting year,” said SVS Nominating Committee Chair Ronald Dalman, MD, who…
Latest iteration of SVS program seeks to help foster development of resilient leaders
As the Society for Vascular Surgery (SVS) prepares to launch its fifth cohort of the Leadership Development Program (LDP), anticipation is high among aspiring leaders in vascular surgery. This seven-month-long program has become a cornerstone for over 100 members of…
Research provides ‘stepping stone’ for future application of AI in vascular surgery
New research on Chat generative pre-trained transformer (GPT) technology and its Vascular Education and Self-Assessment Program (VESAP) success rate provides insight into the future of artificial intelligence (AI) in vascular surgery training and practice, investigators Michael Amendola, MD, and Quang…
Physician-assembled unitary stent graft platform for debranched TAAA repair found safe and effective
Researchers behind a seven-year retrospective analysis of a physician-developed unitary stent graft system for endovascular debranched aortic repair of various thoracoabdominal aortopathies reported a 30-day mortality rate of 3.6%, with an all-cause mortality rate of 23% and an aneurysm-related mortality…
How intersociety collaboration to promote private practice could help vascular surgery amid workforce crisis
Dawn M. Coleman, MD, chief of vascular surgery at the Duke University School of Medicine in Durham, North Carolina, focused on the likely major shortage of vascular surgeons and physicians to illustrate how intersocietal collaboration will help ease this problem…
Bad reading: How to claw back negative revenue?
Five frequently performed vascular surgeries at a prominent New Orleans-based health system between 2019 and 2022 yielded an average yearly decrease in net revenue of -11.5%, lending weight to growing national evidence that lay bare how increasing direct costs are…